Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | 1,522 | 14,543 | 4.92% | +13,021 |
| Nuvation Bio Inc. (NUVB)(NUVB) | 2,541,009 | 2,541,009 | 0 | 3,837 | 9,249 | 3.13% | +5,412 |
| Syndax Pharmaceuticals, Inc. (SNDX)(SNDX) | 1,025,000 | 1,025,000 | 0 | 22,150 | 24,395 | 8.26% | +2,245 |
| CalciMedica, Inc. (CALC)(CALC) | 0 | 521,114 | +521,114 | 0 | 2,168 | 0.73% | +2,168 |
| Monte Rosa Therapeutics Inc (GLUE)(GLUE) | 1,472,331 | 1,472,331 | 0 | 8,319 | 10,380 | 3.51% | +2,061 |
| Biomea Fusion Inc (BMEA)(BMEA) | 798,757 | 798,757 | 0 | 11,598 | 11,941 | 4.04% | +343 |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 288,571 | 0 | 164 | 294 | 0.10% | +130 |
| Aclaris Therapeutics Inc (ACRS)(ACRS) | 434,455 | 434,455 | 0 | 456 | 539 | 0.18% | +83 |
| Reneo Pharmaceuticals Inc (RPHM) | 886,075 | 886,075 | 0 | 1,418 | 1,471 | 0.50% | +53 |
| Atreca Inc. (BCEL) | 387,653 | 0 | -387,653 | 51 | 0 | — | -51 |
| Avrobio, Inc. (AVRO) | 1,009,779 | 1,009,779 | 0 | 1,373 | 1,293 | 0.44% | -81 |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 1,043,267 | 0 | 3,505 | 3,328 | 1.13% | -177 |
| Marker Therapeutics, Inc. (MRKR)(MRKR) | 314,286 | 314,286 | 0 | 1,729 | 1,351 | 0.46% | -377 |
| Compass Pathways Plc (CMPS)(CMPS) | 964,500 | 964,500 | 0 | 8,439 | 8,025 | 2.72% | -414 |
| Spruce Biosciences, Inc. (SPRB) | 1,205,511 | 1,205,511 | 0 | 3,532 | 948 | 0.32% | -2,585 |
| Verona Pharma plc (VRNA) | 1,115,352 | 1,115,352 | 0 | 22,173 | 17,946 | 6.07% | -4,227 |
| BridgeBio Pharma Inc. (BBIO)(BBIO) | 6,068,125 | 6,068,125 | 0 | 244,970 | 187,626 | 63.50% | -57,344 |